Join CBSET at the MDG Boston forum Pathways to Success for MedTech Startups, May 2, 2019, at Nutter McClennen & Fish LLP, 155 Seaport Blvd, Boston, Massachusetts 02210.
This forum will bring together a diverse and experienced panel to discuss strategies for startup conception, funding, development and partnership.
CBSET will be exhibiting at this event. If you would like to meet up with us there, please contact us.
Related CBSET brochures:
Enhanced Plaque Modification of Cadaveric Human Calcified Peripheral Arteries Treated with a Vessel Preparation System. Interview at CRT19 with CBSET’s Director of Research and Innovation, Rami Tzafriri, PhD, about CBSET’s PAD preclinical study using human cadaver model assessment of a vessel preparation system.
World Pharma Today – Cell-based Therapy and FDA Review: Partnering for Success at Your pre-IND Meeting
by Michael Naimark, MS, Director of Business Development at CBSET, Inc.
Science Translational Medicine – Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension. Tzafriri AR, Keating JH, Markham PM, Spognardi AM, L Stanley JR, Wong G, Zani BG, Highsmith D, O’Fallon P, Fuimaono K, Mahfoud F, Edelman ER. Sci Transl Med. 2015 Apr 29;7(285):285ra65. doi: 10.1126/scitranslmed.aaa3236.
Science Translational Medicine – Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia. Oliva N, Carcole M, Beckerman M, Seliktar S, Hayward A, Stanley J, Parry NM, Edelman ER, Artzi N. Sci Transl Med. 2015 Jan 28;7(272):272ra11.